20 September 2017

NICE, 10 Spring Gardens, London

Draft agenda

The meeting will start promptly at 10am and is expected to finish at approximately 4pm.

Please note that this agenda is a draft and is subject to change prior to the meeting.

  1. Welcome and introduction to format of meeting – Part 1 only (open session)
  2. Code of conduct for members of the public attending the meeting – Part 1 only (open session)
  3. Apologies – Part 1 only (open session)
  4. Any other business – Part 1 only (open session)
  5. Minutes from the last Committee meeting held on 19 July 2017 and 22 August 2017 – Part 1 only (open session)
  6. Appraisal of cladribine tablets for treating relapsing-remitting multiple sclerosis [ID64]
    • 6.1. Declarations of interest – Part 1 only (open session)
    • 6.2. Introduction by the Vice Chair, Dr Sanjeev Patel – Part 1 only (open session)
    • 6.3. Presentation by the Lead Team – Part 1 AND part 2 (open and closed session)
    • 6.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  7. Appraisal of tivozanib for treating renal cell carcinoma [ID591]
    • 7.1. Declarations of interest – Part 1 only (open session)
    • 7.2. Introduction by the Chair, Dr Amanda Adler – Part 1 only (open session)
    • 7.3. Presentation by the Chair, Dr Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 7.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)
  8. Appraisal of lenvatinib with everolimus for previously treated advanced renal cell carcinoma [ID1029]
    • 8.1. Declarations of interest – Part 1 only (open session)
    • 8.2. Introduction by the Chair, Dr Amanda Adler – Part 1 only (open session)
    • 8.3. Presentation by the Chair, Dr Amanda Adler – Part 1 AND part 2 (open and closed session)
    • 8.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) – Part 2 only (closed session)

To print an agenda, please right click and select 'Print' from the menu.

Date, time and venue of next meeting

The next meeting will take place on Wednesday 18 October 2017 at NICE London.

Please note all timings are approximate.

How to register

  • Click on the register link below and complete the registration form, selecting the topics you would like to attend.
  • You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.
  • Registration will close on 8 September 2017Please note that it may not be possible to accept late requests. 
  • Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Josh South.
  • Registrants wishing to conduct a research study on committee meetings and/or NICE processes will require prior permission. Contact the NICE Enquiry Handling team at nice@nice.org.uk.
  • Further information about conducting research is also available in our common questions and answers about meetings in public document.

 

Registration period: 25 August 2017 to 08 September 2017
Registration is closed.